 |
PDBsum entry 2bbt
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transport protein
|
PDB id
|
|
|
|
2bbt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structure and dynamics of nbd1 from cftr characterized using crystallography and hydrogen/deuterium exchange mass spectrometry.
|
 |
|
Authors
|
 |
H.A.Lewis,
C.Wang,
X.Zhao,
Y.Hamuro,
K.Conners,
M.C.Kearins,
F.Lu,
J.M.Sauder,
K.S.Molnar,
S.J.Coales,
P.C.Maloney,
W.B.Guggino,
D.R.Wetmore,
P.C.Weber,
J.F.Hunt.
|
 |
|
Ref.
|
 |
J Mol Biol, 2010,
396,
406-430.
|
 |
|
PubMed id
|
 |
|
 |
|
|
 |
 |
|
Abstract
|
 |
|
The DeltaF508 mutation in nucleotide-binding domain 1 (NBD1) of the cystic
fibrosis transmembrane conductance regulator (CFTR) is the predominant cause of
cystic fibrosis. Previous biophysical studies on human F508 and DeltaF508
domains showed only local structural changes restricted to residues 509-511 and
only minor differences in folding rate and stability. These results were
remarkable because DeltaF508 was widely assumed to perturb domain folding based
on the fact that it prevents trafficking of CFTR out of the endoplasmic
reticulum. However, the previously reported crystal structures did not come from
matched F508 and DeltaF508 constructs, and the DeltaF508 structure contained
additional mutations that were required to obtain sufficient protein solubility.
In this article, we present additional biophysical studies of NBD1 designed to
address these ambiguities. Mass spectral measurements of backbone amide
(1)H/(2)H exchange rates in matched F508 and DeltaF508 constructs reveal that
DeltaF508 increases backbone dynamics at residues 509-511 and the adjacent
protein segments but not elsewhere in NBD1. These measurements also confirm a
high level of flexibility in the protein segments exhibiting variable
conformations in the crystal structures. We additionally present crystal
structures of a broader set of human NBD1 constructs, including one harboring
the native F508 residue and others harboring the DeltaF508 mutation in the
presence of fewer and different solubilizing mutations. The only consistent
conformational difference is observed at residues 509-511. The side chain of
residue V510 in this loop is mostly buried in all non-DeltaF508 structures but
completely solvent exposed in all DeltaF508 structures. These results reinforce
the importance of the perturbation DeltaF508 causes in the surface topography of
NBD1 in a region likely to mediate contact with the transmembrane domains of
CFTR. However, they also suggest that increased exposure of the 509-511 loop and
increased dynamics in its vicinity could promote aggregation in vitro and
aberrant intermolecular interactions that impede trafficking in vivo.
|
 |
|
|
|
|
 |